AI assistant
BIOGEN INC. — Director's Dealing 2011
Apr 21, 2011
30291_dirs_2011-04-21_0c53007b-6310-4e24-b2b9-ecba4095ce5a.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BIOGEN IDEC INC. (BIIB)
CIK: 0000875045
Period of Report: 2011-04-20
Reporting Person: SCHENK LYNN (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2011-04-20 | Common Stock | M | 10000 | $68.15 | Acquired | 17980 | Direct |
| 2011-04-20 | Common Stock | S | 10000 | $85.8086 | Disposed | 7980 | Direct |
| 2011-04-20 | Common Stock | M | 12500 | $66.29 | Acquired | 20480 | Direct |
| 2011-04-20 | Common Stock | M | 3125 | $46.99 | Acquired | 23605 | Direct |
| 2011-04-20 | Common Stock | M | 5950 | $52.22 | Acquired | 29555 | Direct |
| 2011-04-20 | Common Stock | M | 5700 | $59.17 | Acquired | 35255 | Direct |
| 2011-04-20 | Common Stock | S | 27275 | $85.00 | Disposed | 7980 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2011-04-20 | Stock Option (Right to Buy) | $68.15 | M | 10000 | Disposed | 2012-01-01 | Common Stock (10000) | Direct |
| 2011-04-20 | Stock Option (Right to Buy) | $66.29 | M | 12500 | Disposed | 2015-01-03 | Common Stock (12500) | Direct |
| 2011-04-20 | Employee Stock Option (Right to Buy) | $46.99 | M | 3125 | Disposed | 2016-05-24 | Common Stock (3125) | Direct |
| 2011-04-20 | Stock Option (Right to Buy) | $52.22 | M | 5950 | Disposed | 2017-05-30 | Common Stock (5950) | Direct |
| 2011-04-20 | Stock Option (Right to Buy) | $59.17 | M | 5700 | Disposed | 2018-06-18 | Common Stock (5700) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 7600 | Indirect |
Footnotes
F1: Exercise/sale pursuant to a trading plan intended to comply with Rule 10b5-1 of the Securities Exchange Act of 1934.
F2: This represents the weighted average price for shares sold at a range between $85.78 (low) and $85.86 (high).
F3: Full information regarding the number of shares sold at each separate price will be provided upon request by the SEC staff, the issuer, or a security holder of the issuer.
F4: Granted under one of the Issuer's stock option plans, in an exempt transaction under SEC rule 16(b)-3(d).
F5: Immediately exercisable for all the option shares on grant date of 01/03/2005 subject to Issuer's repurchase rights which lapse on 01/03/2006.
F6: Options will vest in their entirety on 05/25/2007 provided that the Reporting Owner is then a member of the Issuer's Board of Directors.
F7: Options will become 100% exercisable upon completion of one year of service with Biogen Idec Inc.